Collegium Pharmaceutical, Inc (COLL) SEC Filings — 2025
13 SEC filings for Collegium Pharmaceutical, Inc (COLL) in 2025.
Filings
- Collegium Pharmaceutical, Inc 8-K Filing — 8-K · Dec 30, 2025
- Collegium Pharma's Q3 Net Income Soars 237% on Strong Revenue Growth — 10-Q · Nov 6, 2025
- Collegium Accelerates Share Buybacks, Boosts Equity Plan — 10-Q · Aug 7, 2025
- Collegium Pharmaceutical Files 8-K — 8-K · Jul 7, 2025
- Collegium Pharmaceutical Files 8-K on Officer/Director Changes — 8-K · May 19, 2025
- Collegium Pharmaceutical Files 8-K: Other Events — 8-K · May 12, 2025
- Collegium Pharmaceutical Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Collgium Pharma Files Proxy Statement — DEFA14A · Mar 28, 2025
- Collegium Pharma Files 2024 Proxy Statement — DEF 14A · Mar 28, 2025
- Collegium Pharma Elects New Directors, Adjusts Officer Compensation — 8-K · Mar 17, 2025
- Collegium Pharmaceutical Files 2024 10-K — 10-K · Feb 27, 2025
- Collegetium Pharma Elects New Directors, Updates Exec Pay — 8-K · Feb 5, 2025
- Collegium Pharmaceutical Files 8-K Report — 8-K · Jan 8, 2025